Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSIt typically takes 10-15 years and billions of dollars to bring a new drug to market, but fewer than 12% of drugs even make it through clinical development.
IQVIA’s Drug Discovery & Development Services provide solutions aimed at minimizing these barriers. The goal of our service offerings is to drive innovation in pharmaceutical R&D by focusing on expediting drug design and development through the prediction of clinical trial success.
With advances in high-throughput technologies and data management systems, there are now vast datasets to be applied in the field of biomedicine to provide more in-depth insights needed to fail early and fast, then make evidence-based, informed decisions. Utilizing IQVIA’s unparalleled data, our highly skilled machine learning engineers and data scientists produce solutions that shorten the development cycle.
These machine learning platforms and advanced AI models can do everything from helping generate new and stable molecular compounds to predicting the technical and regulatory success of a drug for a given indication. Drug Discovery & Development Services uncover new opportunities for companies and help them adapt to challenges with speed, agility, and confidence.
Computational methods rooted in deep learning are leveraged to automate the molecular generation process for both identifying novel targets and designing new lead compounds. Targets are validated by identifying interactions early in the discovery process with lead target interaction, and by comparing with research literature using natural language extraction (NLE). This innovative approach enables greater productivity and shortens timelines needed to identify potential new molecules for investigation or refine existing molecules.
Identifying patients who would benefit most from specialized treatments is transforming personalized medicine. AI-powered biomarker identification and validation supports R&D by identifying potential patients through prognostic and predictive markers to better profile patient subpopulations ahead of trial start up. Biomarkers include demographic, genetic and clinical data points. Biomarkers of interest are identified and validated through innovative approaches, such as deep computational phenotyping, to aid in patient stratification and increase knowledge of disease progression. Utilizing patient subpopulations derived through biomarker identification can increase trial success while lessening enrollment timelines and reducing costs.
Repurposing approved drugs and those that have proven safety in Phase I/II trials saves vast amounts of clinical development time and money. By mining existing and failed compounds, assets and drugs for new uses, sponsors can focus solely on the clinical testing portion of the approval process, shortening development timelines and improving the probability of clinical trial success.
AI approaches used to maximize the value of existing drugs include literature extraction using natural language processing (NLP), machine learning from bioinformatics data, and mining of electronic medical records (EMR) and claims data.
We have built drug repurposing in such a way that it can look at the available chemical space — our approaches are disease and treatment agnostic. We can run pipelines for drug property, drug-to-drug interaction, drug target interaction, protein function, and protein-to-protein interaction predictions. All with a goal of augmenting the speed, accuracy, and cost of conducting these processes.
Validate drug assets in development using AI/ML-powered technology that identifies predictions of the probability of technical and regulatory success for a given indication. IQVIA offers a tremendous depth and breadth of data with predictions based off more than 54,000 pathways, providing a snapshot of the entire clinical pipeline database.
Gain a competitive advantage by getting rapid insights into approved assets, those that are soon to be in the market, and those likely to enter in the future. These insights support better, faster business decisions while minimizing the overall resources and costs required for investment efforts.
These innovative solutions help produce novel drug designs, predict patient subpopulations for trial and protocol design, augment R&D teams with proven expertise and optimize trial success—all which can greatly reduce timelines and costs. IQVIA provides the global scale and expertise to reveal unseen insights, drive smarter decisions and discover new opportunities faster.
For more information on how to innovate to succeed, visit IQVIA’s Drug Discovery & Development Services.
IQVIA's Drug Discovery & Development Services use AI and machine learning to transform R&D and expedite the drug discovery and development process.
Discover unrealized connections and manage your product across the entire lifecycle, from research and development, compliance to launch and commercialization.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
